Journal of Clinical Endocrinology & Metabolism, Vol 69, 1033-1039, Copyright © 1989 by Endocrine Society

ARTICLES

Dynamic changes in circulating inhibin levels during the luteal- follicular transition of the human menstrual cycle

SJ Roseff, ML Bangah, LM Kettel, W Vale, J Rivier, HG Burger and SS Yen
Department of Reproductive Medicine, School of Medicine, University of California 92037.

Dynamic changes in serum immunoreactive (ir) inhibin levels during the transition from the luteal to the follicular phase (luteal-follicular transition) were characterized during 3 consecutive cycles in 12 cycling women. Both spontaneous (first to second cycle) and GnRH antagonist-imposed premature luteolysis (second to third cycle) were evaluated. Serum FSH, LH, estradiol (E2), and progesterone (P4) levels were monitored daily by RIA for the entire study. Daily ir-inhibit levels were determined from 7 days before until 7 days after the onset of menses and from 4 days before to 10 days after the GnRH antagonist- induced bleeding by a heterologous RIA. During spontaneous luteolysis, ir-inhibin levels peaked 7 days before menses and declined in a linear fashion (r = -0.99) thereafter, reaching a sustained low level 1 day after the onset of menses. The decline of P4 and E2 levels appears to be coupled to that of ir-inhibin (r = 0.98 and r = 0.95, respectively). FSH levels showed an inverse pattern, with an acute elevation unaccompanied by LH, for 5 days before the onset of menses and reaching a plateau 2 days after. ir-Inhibin and FSH were negatively correlated (r = -0.87; P less than 0.0001). Increased LH levels did not occur until the day of menses and were negatively correlated with ir-inhibin (r = -0.50; P less than 0.05), but not E2 and P4. During the second cycle, at the midluteal phase luteolysis was induced by a single (50 micrograms/kg) im injection of a potent GnRH antagonist, [Ac- D2Nal,D4ClPhe2,D3Pal3,Arg5,DGlu6(AA),+ ++DAla10] GnRH; an acute decline of LH and FSH levels occurred, with maximal suppressions of 51% and 35%, respectively. ir-Inhibin levels decreased rapidly (40 +/- 2.8%) in parallel with E2 and P4 during the first 24 h and continued to decline for 4 days. The inverse relationship and time course of changes between FSH and ir-inhibin levels were similar to those of the spontaneous luteal-follicular transition. Six of the 12 subjects experienced partial reversal of luteolysis; the decline of ir-inhibin and the rise of FSH during the first 2 days were arrested for 4 days, which corresponded to the rebound increases in E2, P4, and LH. The subsequent fall of ir-inhibin was followed by a rise in FSH. Both the complete and incomplete luteolysis groups exhibited an orderly follicular maturation, LH surge, and luteal function during the ensuing cycle.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				I. E. Messinis Ovarian feedback, mechanism of action and possible clinical implications Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571. [Abstract] [Full Text] [PDF]

				K. R. Hansen, A. C. Thyer, P. M. Sluss, W. J. Bremner, M. R. Soules, and N. A. Klein Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women? Hum. Reprod., January 1, 2005; 20(1): 89 - 95. [Abstract] [Full Text] [PDF]

				K. Dafopoulos, C.G. Kotsovassilis, S. Milingos, A. Kallitsaris, G. Galazios, E. Zintzaras, P. Sotiros, and I.E. Messinis Changes in pituitary sensitivity to GnRH in estrogen-treated post-menopausal women: evidence that gonadotrophin surge attenuating factor plays a physiological role Hum. Reprod., September 1, 2004; 19(9): 1985 - 1992. [Abstract] [Full Text] [PDF]

				N. A. Klein, B. S. Houmard, K. R. Hansen, T. K. Woodruff, P. M. Sluss, W. J. Bremner, and M. R. Soules Age-Related Analysis of Inhibin A, Inhibin B, and Activin A Relative to the Intercycle Monotropic Follicle-Stimulating Hormone Rise in Normal Ovulatory Women J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2977 - 2981. [Abstract] [Full Text] [PDF]

				R. Fanchin, L. Salomon, A. Castelo-Branco, F. Olivennes, N. Frydman, and R. Frydman Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists Hum. Reprod., December 1, 2003; 18(12): 2698 - 2703. [Abstract] [Full Text] [PDF]

				D. de Ziegler Associate editor's commentary: The dawning of the non-cancer uses of aromatase inhibitors in gynaecology Hum. Reprod., August 1, 2003; 18(8): 1598 - 1602. [Full Text] [PDF]

				N. A. Klein, A. J. Harper, B. S. Houmard, P. M. Sluss, and M. R. Soules Is the Short Follicular Phase in Older Women Secondary to Advanced or Accelerated Dominant Follicle Development? J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5746 - 5750. [Abstract] [Full Text] [PDF]

				S. P. Tofovic, R. Dubey, E. M. Salah, and E. K. Jackson 2-Hydroxyestradiol Attenuates Renal Disease in Chronic Puromycin Aminonucleoside Nephropathy J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2737 - 2747. [Abstract] [Full Text] [PDF]

				F.P. Hohmann, J.S.E. Laven, F.H. de Jong, M.J.C. Eijkemans, and B.C.J.M. Fauser Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development Hum. Reprod., May 1, 2001; 16(5): 846 - 854. [Abstract] [Full Text] [PDF]

				C. K. Welt, J. M. Adams, P. M. Sluss, and J. E. Hall Inhibin A and Inhibin B Responses to Gonadotropin Withdrawal Depends on Stage of Follicle Development J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2163 - 2169. [Abstract] [Full Text]

				E. W. Seely, B. W. Walsh, M. D. Gerhard, and G. H. Williams Estradiol With or Without Progesterone and Ambulatory Blood Pressure in Postmenopausal Women Hypertension, May 1, 1999; 33(5): 1190 - 1194. [Abstract] [Full Text] [PDF]

				M. Gerhard, B. W. Walsh, A. Tawakol, E. A. Haley, S. J. Creager, E. W. Seely, P. Ganz, and M. A. Creager Estradiol Therapy Combined With Progesterone and Endothelium-Dependent Vasodilation in Postmenopausal Women Circulation, September 22, 1998; 98(12): 1158 - 1163. [Abstract] [Full Text] [PDF]

				C. K. Welt, K. A. Martin, A. E. Taylor, G. M. Lambert-Messerlian, W. F. Crowley Jr., J. A. Smith, D. A. Schoenfeld, and J. E. Hall Frequency Modulation of Follicle-Stimulating Hormone (FSH) during the Luteal-Follicular Transition: Evidence for FSH Control of Inhibin B in Normal Women J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2645 - 2652. [Abstract] [Full Text] [PDF]

				B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text]